Technology | Computer-Aided Detection Software | May 21, 2019

MaxQ AI Launches Accipio Ax Slice-Level Intracranial Hemorrhage Detection

Artificial intelligence solution includes the SliceMap and slice-level preview to facilitate rapid intracranial hemorrhage detection and efficient clinical workflow

MaxQ AI Launches Accipio Ax Slice-Level Intracranial Hemorrhage Detection

May 21, 2019 – Medical diagnostic artificial intelligence (AI) company MaxQ AI announced that Accipio Ax will begin shipping in August and will be available as the second part of the Accipio ICH Platform. Accipio Ax will provide new tools to support clinical assessment of intracranial hemorrhage (ICH). Radiology departments, emergency room and neuroradiology teams across the U.S. and the EU will soon be able to access a comprehensive solution for ICH triage through workflow prioritization and slice-level preview. Accipio Ax includes the exclusive Accipio Ax SliceMap, an integrated view which guides clinicians rapidly to computed tomography (CT) slices with suspected ICH without leaving their picture archiving and communication system (PACS) viewer.

With regulatory approvals and a U.S. Food and Drug Administration (FDA) Breakthrough Device designation for Accipio Dx – MaxQ AI’s Accipio suite of software is a fully-automated solution integrated by major original equipment manufacturer (OEM) CT, PACS and AI ecosystem partners. With the potential for improving detection and workflow for suspected ICH, these solutions enable faster and more accurate treatment of patients.   

“Each month Accipio Ix processes nearly 1,000 head CT scans, including upwards of 30 stroke cases per week, at Capital Health,” said Ajay Choudhri, M.D., chairman of the Department of Radiology at Capital Health Hospitals in New Jersey. “With Accipio Ax, we can now benefit from a comprehensive solution for triage through workflow prioritization and slice-level preview of ICH, including the exclusive Accipio Ax SliceMap, which guides users rapidly to CT images with suspected ICH.”

With less money than ever before and a shortage of healthcare providers attempting to serve a growing number of patients, medical diagnostic AI solutions have the potential to fill a critical void within the healthcare system. It is projected that there will be 3.4 million stroke victims by 2030, which will cause loss or extreme hardships for patients and their families, while generating $240 billion in total direct and indirect costs.1

The Accipio ICH Platform, the complete ICH solution for stroke and head trauma assessment, promises to help address this by greatly increasing intracranial hemorrhage (ICH) detection and reducing missed ICH through near real-time triage, annotation and diagnostic rule-out.

MaxQ AI is demonstrating the full suite of Accipio ICH Platform solutions during the 57th American Society of Neuroradiology (ASNR) Annual Meeting, May 18-23 in Boston.

For more information: www.maxq.ai

 

Related Content

MaxQ AI Receives FDA Clearance for Accipio Ix Intracranial Hemorrhage Platform

MaxQ AI's Accipio Software Integrated to GE's Smart Subscription Platform

VIDEO: How Artificial Intelligence Can Detect Brain Bleeds

 

Reference

1. Forecasting the future of stroke in the United States: a policy statement from the American Heart Association and American Stroke Association. Stroke. 2013 Aug;44(8):2361-75. doi: 10.1161/STR.0b013e31829734f2

Related Content

Imaging center leaders and radiologists identify benefits, challenges and areas of use associated with artificial intelligence usage in healthcare

Image by Gerd Altmann from Pixabay 

News | Artificial Intelligence | January 28, 2020
January 28, 2020 — Definitive Healthcare, a provider of da

Image by Adam Radosavljevic from Pixabay 

News | Radiology Business | January 27, 2020
January 27, 2020 —  Hg, a specialist private equity investor focused on software and service businesses, announced th
he U.S. Food and Drug Administration (FDA) has issued a final order to reclassify medical image analyzers applied to mammography breast cancer, ultrasound breast lesions, radiograph lung nodules and radiograph dental caries detection, postamendments class III devices (regulated under product code MYN), into class II (special controls), subject to premarket notification

Image courtesy of iCAD

News | Computer-Aided Detection Software | January 22, 2020
January 22, 2020 — The U.S.
Iodine-based CT contrast ready for scanning with a Canon Aquilion One 320-slice CT system at Northwestern Medicine Central DuPage Hospital in the Chicago suburbs.
News | Radiology Imaging | January 22, 2020
January 22, 2020 — The risk of administering modern...
Medical imaging technology company Oxipit announced partnership with Swiss medical distribution company Healthcare Konnect to bring ChestEye AI imaging suite to healthcare institutions in Nigeria
News | Artificial Intelligence | January 22, 2020
January 22, 2020 — Medical imaging technology company Oxipit ann
Hitachi Healthcare Americas announced that it will create a new dedicated research and development facility within its North American headquarters facility in Twinsburg, Ohio
News | Radiology Business | January 21, 2020
January 21, 2020 — Hitachi Healthcare Americas announced that it will create a new dedicated research and development
Sponsored Content | Videos | Enterprise Imaging | January 20, 2020
GE Healthcare's iCenter is a cloud-based management software that provides 24/7 visibility to customers' visual and o
This is a lung X-ray reviewed automatically by artificial intelligence (AI) to identify a collapsed lung (pneumothorax) in the color coded area. This AI app from Lunit is awaiting final FDA review and in planned to be integrated into several vendors' mobile digital radiography (DR) systems. Fujifilm showed this software integrated as a work-in-progress into its mobile X-ray system at RSNA 2019. GE Healthcare has its own version of this software for its mobile r=ray systems that gained FDA in 2019.   #RSNA #

This is a lung X-ray reviewed automatically by artificial intelligence (AI) to identify a collapsed lung (pneumothorax) in the color coded area. This AI app from Lunit is awaiting final FDA review and in planned to be integrated into several vendors' mobile digital radiography (DR) systems. Fujifilm showed this software integrated as a work-in-progress into its mobile X-ray system at RSNA 2019. GE Healthcare has its own version of this software for its mobile r=ray systems that gained FDA in 2019.

Feature | RSNA | January 20, 2020 | Dave Fornell, Editor
Here are images of some of the newest new medical imaging technologies displayed on the expo floor at the ...